Newsroom
Monarch Technologies receives CHF 40,000 from Venture Kick to accelerate validation toward clinical translation
16.06.2026
Monarch Technologies receives CHF 40,000 from Venture Kick to advance its adaptive drug delivery platform for locoregional cancer ... more
SonoStent receives CHF 40,000 from Venture Kick to advance non-invasive urinary stent technology
16.06.2026
SonoStent receives CHF 40,000 from Venture Kick to advance its ultrasound-activated technology for urinary stents and catheters. B ... more
Immitra Bio receives CHF 150,000 from Venture Kick to reimagine stem cell therapy for rare diseases
15.06.2026
The ETH spin-off Immitra Bio has received CHF 150,000 from Venture Kick to develop a new treatment approach for rare genetic disea ... more
Newsletter Archive
Momentum Beyond the Lab 🧪
Spring momentum across Swiss startups 🌱
A record 2025, and kicking bigger in 2026! 🚀
Press releases
Press review
1000 Unternehmen mit Venture Kick gegründet
Media contacts
For media enquiries, please email our communications team. If you have a general question about Venture Kick please visit our about us page.
Learn more about Venture Kick or download the latest annual report for detailed information.
